Skip to content

Study · Ex vivo tissue · 2015

10 results

Human cathelicidin antimicrobial protein 18 (hCAP18/LL-37) is increased in foetal membranes and myometrium after spontaneous labour and delivery.

Lim R, Barker G, Lappas M

Journal of reproductive immunology11 Nov 2014Cited by 15 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study10

7 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabEx vivo tissueActivity measurement

    In human foetal membrane and myometrium explants, LL‑37 significantly induced expression and secretion of IL-6.

    In plain wordsIn lab-tested human pregnancy tissue, LL‑37 raised the inflammatory signal IL-6.

    Peptide
    LL-37
    Outcome
    IncreaseIL-6 expression and secretion
    Study

    humann: not reported in source

    Foetal membrane and myometrium explants
    Outcome group
    Inflammation markers · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Treatment of foetal membranes and myometrium with LL-37 significantly induced the expression and secretion of the pro-inflammatory cytokines IL-6 and TNF-α, and the chemokines IL-8 and MCP-1.
    1 context sentence
    Summary · context
    The aim of this study was to determine the effect of human labour on hCAP18 expression in foetal membranes and myometrium, and to determine the effect of the synthetic LL-37 peptide on pro-inflammatory and pro-labour mediators in foetal membranes and myometrium.
  2. 02LabEx vivo tissueActivity measurement

    In human foetal membrane and myometrium explants, LL‑37 significantly induced expression and secretion of TNF-α.

    In plain wordsIn lab-tested human pregnancy tissue, LL‑37 raised the inflammatory signal TNF-α.

    Peptide
    LL-37
    Outcome
    IncreaseTNF-α expression and secretion
    Study

    humann: not reported in source

    Foetal membrane and myometrium explants
    Outcome group
    Inflammation markers · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Treatment of foetal membranes and myometrium with LL-37 significantly induced the expression and secretion of the pro-inflammatory cytokines IL-6 and TNF-α, and the chemokines IL-8 and MCP-1.
    1 context sentence
    Summary · context
    The aim of this study was to determine the effect of human labour on hCAP18 expression in foetal membranes and myometrium, and to determine the effect of the synthetic LL-37 peptide on pro-inflammatory and pro-labour mediators in foetal membranes and myometrium.
  3. 03LabEx vivo tissueActivity measurement

    In human foetal membrane and myometrium explants, LL‑37 significantly induced expression and secretion of the chemokine IL-8.

    In plain wordsIn lab-tested human pregnancy tissue, LL‑37 raised the chemokine IL-8.

    Peptide
    LL-37
    Outcome
    IncreaseIL-8 expression and secretion
    Study

    humann: not reported in source

    Foetal membrane and myometrium explants
    Outcome group
    Inflammation markers · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Treatment of foetal membranes and myometrium with LL-37 significantly induced the expression and secretion of the pro-inflammatory cytokines IL-6 and TNF-α, and the chemokines IL-8 and MCP-1.
    1 context sentence
    Summary · context
    The aim of this study was to determine the effect of human labour on hCAP18 expression in foetal membranes and myometrium, and to determine the effect of the synthetic LL-37 peptide on pro-inflammatory and pro-labour mediators in foetal membranes and myometrium.
  4. 04LabEx vivo tissueActivity measurement

    In human foetal membrane and myometrium explants, LL‑37 significantly induced expression and secretion of the chemokine MCP-1.

    In plain wordsIn lab-tested human pregnancy tissue, LL‑37 raised the chemokine MCP-1.

    Peptide
    LL-37
    Outcome
    IncreaseMCP-1 expression and secretion
    Study

    humann: not reported in source

    Foetal membrane and myometrium explants
    Outcome group
    Inflammation markers · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Treatment of foetal membranes and myometrium with LL-37 significantly induced the expression and secretion of the pro-inflammatory cytokines IL-6 and TNF-α, and the chemokines IL-8 and MCP-1.
    1 context sentence
    Summary · context
    The aim of this study was to determine the effect of human labour on hCAP18 expression in foetal membranes and myometrium, and to determine the effect of the synthetic LL-37 peptide on pro-inflammatory and pro-labour mediators in foetal membranes and myometrium.
  5. 05LabEx vivo tissueActivity measurement

    In human foetal membrane explants, LL‑37 induced expression of MMP-9 mRNA.

    In plain wordsIn lab-tested human foetal membranes, LL‑37 raised the gene signal for MMP-9.

    Peptide
    LL-37
    Outcome
    IncreaseMMP-9 mRNA expression in foetal membranes
    Study

    humann: not reported in source

    Foetal membrane explants
    Outcome group
    Inflammation markers · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    LL-37 also induced expression of MMP-9 mRNA and pro MMP-9 expression in foetal membranes.
    1 context sentence
    Summary · context
    The aim of this study was to determine the effect of human labour on hCAP18 expression in foetal membranes and myometrium, and to determine the effect of the synthetic LL-37 peptide on pro-inflammatory and pro-labour mediators in foetal membranes and myometrium.
  6. 06LabEx vivo tissueActivity measurement

    In human foetal membrane explants, LL‑37 induced expression of pro MMP-9 protein.

    In plain wordsIn lab-tested human foetal membranes, LL‑37 raised pro MMP-9 protein.

    Peptide
    LL-37
    Outcome
    IncreasePro MMP-9 protein expression in foetal membranes
    Study

    humann: not reported in source

    Foetal membrane explants
    Outcome group
    Inflammation markers · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    LL-37 also induced expression of MMP-9 mRNA and pro MMP-9 expression in foetal membranes.
    1 context sentence
    Summary · context
    The aim of this study was to determine the effect of human labour on hCAP18 expression in foetal membranes and myometrium, and to determine the effect of the synthetic LL-37 peptide on pro-inflammatory and pro-labour mediators in foetal membranes and myometrium.
  7. 07LabEx vivo tissueMechanism

    In human foetal membrane and myometrium samples, LL‑37 significantly increased NF-κB transcriptional activity.

    In plain wordsIn lab-tested human pregnancy tissue, LL‑37 increased the activity of NF-κB, a switch for inflammation genes.

    Peptide
    LL-37
    Outcome
    IncreaseNF-κB transcriptional activity
    Study

    humann: not reported in source

    Foetal membrane and myometrium tissue and cells
    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    LL-37 also significantly increased NF-κB transcriptional activity.
    1 context sentence
    Summary · context
    The aim of this study was to determine the effect of human labour on hCAP18 expression in foetal membranes and myometrium, and to determine the effect of the synthetic LL-37 peptide on pro-inflammatory and pro-labour mediators in foetal membranes and myometrium.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 08HumanEndogenous levelObservational studyOther

    In human foetal membranes and myometrium, hCAP18 (the LL‑37 precursor) protein expression was higher after labour than in tissue without labour.

    In plain wordsIn human pregnancy tissue, the body's own LL‑37 precursor protein was higher after labour began.

    Peptide
    LL-37
    Outcome
    IncreasehCAP18 protein expression in labour versus non-labour tissue
    Study

    n: not reported in source

    Comparator
    Non-labouring tissue
    Outcome group
    Immune response · Reproductive and sexual health

    Source sentences

    Summary
    In foetal membranes and myometrium, human labour was associated with significantly higher hCAP18 protein expression.
    1 context sentence
    Summary · context
    The aim of this study was to determine the effect of human labour on hCAP18 expression in foetal membranes and myometrium, and to determine the effect of the synthetic LL-37 peptide on pro-inflammatory and pro-labour mediators in foetal membranes and myometrium.

    This result measures the body's own LL-37. Nobody was given the peptide. It is not evidence about taking it.

Studies that did not test the peptide alone2

In this study, LL-37 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking LL-37.

  1. 09LabNot a test of LL-37 aloneEx vivo tissueMechanism

    In human foetal membrane and myometrium explants, co-treatment with BAY 11-7082 decreased the pro-inflammatory cytokine expression induced by LL‑37.

    In plain wordsIn lab-tested human pregnancy tissue, the NF-κB blocker BAY 11-7082 reduced the inflammatory signals that LL‑37 caused.

    Peptide
    LL-37
    Outcome
    DecreaseBAY 11-7082 effect on LL-37-induced cytokine expression
    Study

    humann: not reported in source

    Foetal membrane and myometrium explants
    Comparator
    LL-37 alone
    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health

    Source sentences

    Summary
    Co-treatment with BAY 11-7082 was associated with a decrease in LL-37-induced pro-inflammatory cytokine expression.
    1 context sentence
    Summary · context
    The aim of this study was to determine the effect of human labour on hCAP18 expression in foetal membranes and myometrium, and to determine the effect of the synthetic LL-37 peptide on pro-inflammatory and pro-labour mediators in foetal membranes and myometrium.

    In this study, LL-37 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking LL-37.

  2. 10LabNot a test of LL-37 aloneIn vitro (cells)Mechanism

    In human myometrial cells, inhibition of MyD88 decreased the pro-inflammatory cytokine expression and release induced by LL‑37.

    In plain wordsIn human uterine muscle cells, blocking MyD88 reduced the inflammatory signals that LL‑37 caused.

    Peptide
    LL-37
    Outcome
    DecreaseMyD88 inhibition effect on LL-37-induced cytokine expression and release
    Study

    humann: not reported in source

    Myometrial cells
    Comparator
    LL-37 alone
    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health

    Source sentences

    Summary
    Moreover, inhibition of MyD88 in myometrial cells decreased LL-37-induced pro-inflammatory cytokine expression and release.
    1 context sentence
    Summary · context
    The aim of this study was to determine the effect of human labour on hCAP18 expression in foetal membranes and myometrium, and to determine the effect of the synthetic LL-37 peptide on pro-inflammatory and pro-labour mediators in foetal membranes and myometrium.

    In this study, LL-37 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking LL-37.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    9 Oct 2026, 18:17 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 02:57 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.